Units to mg calculator
Runs in your browser. What you enter stays on your device.
How this works
The calculator divides the units you draw by 100 to get the volume in milliliters, because 100 units on a U-100 insulin syringe is 1 mL. It then multiplies that volume by the strength of your vial in milligrams per milliliter.
Example: 20 units from a 2.5 mg/mL vial is 0.2 mL, and 0.2 × 2.5 is 0.5 mg.
Units measure liquid, not medicine. The same number of units holds a different dose in a vial of a different strength.
Compounded vials are not FDA-approved, and their strength varies from one pharmacy to the next. That is why FDA has reported dosing errors with them. Read dosing errors: mg, mL and units before you measure a dose, and call the pharmacy that supplied the vial if its label and your instructions do not match.
What 10, 20 and 50 units hold at each vial strength
| Vial strength | 10 units | 20 units | 50 units |
|---|---|---|---|
| Semaglutide 1 mg/mL | 0.1 mg | 0.2 mg | 0.5 mg |
| Semaglutide 2 mg/mL | 0.2 mg | 0.4 mg | 1 mg |
| Semaglutide 2.5 mg/mL | 0.25 mg | 0.5 mg | 1.25 mg |
| Semaglutide 3 mg/mL | 0.3 mg | 0.6 mg | 1.5 mg |
| Semaglutide 5 mg/mL | 0.5 mg | 1 mg | 2.5 mg |
| Tirzepatide 5 mg/mL | 0.5 mg | 1 mg | 2.5 mg |
| Tirzepatide 10 mg/mL | 1 mg | 2 mg | 5 mg |
| Tirzepatide 15 mg/mL | 1.5 mg | 3 mg | 7.5 mg |
| Tirzepatide 20 mg/mL | 2 mg | 4 mg | 10 mg |
| Tirzepatide 30 mg/mL | 3 mg | 6 mg | 15 mg |
Charts for other vial strengths
- Semaglutide 1 mg/mL dosage chart
- Semaglutide 2 mg/mL dosage chart
- Semaglutide 2.5 mg/mL dosage chart
- Semaglutide 3 mg/mL dosage chart
- Semaglutide 5 mg/mL dosage chart
- Tirzepatide 5 mg/mL dosage chart
- Tirzepatide 10 mg/mL dosage chart
- Tirzepatide 15 mg/mL dosage chart
- Tirzepatide 20 mg/mL dosage chart
- Tirzepatide 30 mg/mL dosage chart
Frequently asked questions
How do I convert units to mg?
Divide the units by 100 to get milliliters, then multiply by your vial strength in mg per mL. Example: 20 units from a 2.5 mg/mL semaglutide vial is 0.2 mL, and 0.2 × 2.5 is 0.5 mg.
Is 10 units the same dose for everyone?
No. 10 units is always 0.1 mL of liquid on a U-100 syringe, but the milligrams in it depend on the vial strength. 10 units is 0.25 mg at 2.5 mg/mL and 0.5 mg at 5 mg/mL.
How many mg is 20 units of semaglutide?
20 units is 0.2 mL. At 2.5 mg per mL that is 0.5 mg of semaglutide; at 5 mg per mL it is 1 mg. Use the strength printed on your own vial.
How many mg is 50 units of tirzepatide?
50 units is 0.5 mL. At 10 mg per mL that is 5 mg of tirzepatide; at 20 mg per mL it is 10 mg. Use the strength printed on your own vial.
Where do I find my vial strength?
It is printed on the vial label in mg per mL (mg/mL). If the label shows only a total, such as 10 mg in 2 mL, divide the milligrams by the milliliters: 10 ÷ 2 is 5 mg per mL. If you cannot find it, call the pharmacy that supplied the vial.
Sources (3)
- 1.FDA: FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
“The majority of the reports described patients mistakenly drawing up more than the prescribed dose from a multiple-dose vial during self-administration. In these instances, patients administered five to 20 times more than the intended dose of semaglutide. Most of the reports indicated that patients were unfamiliar with how to measure the intended dose using a syringe.”
- 2.FDA: FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
“Additionally, the instructions that accompany the compounded drug, if provided, may instruct users to administer semaglutide injections in “units” (the volume of which may vary depending on the concentration), rather than milligrams or milliliters. FDA is aware of some instances in which patients have been given syringes that are significantly larger than the prescribed volume of semaglutide (see example in Figure 1).”
- 3.FDA: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
“FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products. These dosing errors resulted from patients measuring and self-administering incorrect doses of the drug, and in some cases, health care professionals miscalculating doses of the drug.”
